Clinical Trial Update: APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing an ongoing Phase 1/2 study of APG-115 in combination with a PD-1 inhibitor for patients with liposarcoma or other advanced soli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma
• Solid Tumors

Drugs mentioned

• APG-115 (APG-115)
• PD-1 inhibitor

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Liposarcoma, Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING